AMPK激活剂在小鼠术后疼痛模型中的抗痛觉过敏效应
该研究在小鼠足底切口术后疼痛模型中,于术后4小时起连续3天口服二甲双胍200 mg/kg、O304 200 mg/kg或二者联用,发现单药均可降低机械性痛觉过敏,联用效果更强,并逆转DRG中AMPK通路异常。
要点
- 术后早期口服O304或二甲双胍可减轻小鼠切口后机械性痛觉过敏。
- 两药联用对von Frey阈值的提升效果优于单药。
- 药物作用伴随DRG内AMPKα下调及mTOR、eIF2α上调的逆转。
核心结论
- 术后早期使用机制特异性AMPK激活剂O304或原型激活剂二甲双胍可减轻小鼠术后疼痛模型的机械性痛觉过敏,并使DRG中AMPK通路正常化。
研究设计与样本
- 小鼠左后足底切口术后疼痛模型,随机分为4组口服灌胃(每组n=8):溶媒、二甲双胍200 mg/kg、O304 200 mg/kg、O304 200 mg/kg联合二甲双胍200 mg/kg。
- 术后4小时首次灌胃,重复3天;用von Frey纤维测机械性痛觉过敏,免疫组化检测DRG神经元中p-AMPKα、p-mTOR和p-eIF2α变化。
主要发现
- O304或二甲双胍在术后第1至4天较溶媒组提高von Frey阈值(曲线下面积均数差:O304为2.24 g*day,95%CI 0.28至4.21,p=0.011;二甲双胍为2.56 g*day,95%CI 1.71至3.41,p<0.001)。
- 两药联用进一步升高von Frey阈值。
- 溶媒组DRG神经元中AMPKα下调、mTOR和eIF2α上调,AMPK激活剂治疗可逆转这些改变。
临床怎么用
- 提示术后早期激活AMPK可能成为术后疼痛管理的潜在策略,尤其二甲双胍为已上市药物。
- 机制上涉及DRG内AMPK/mTOR/eIF2α通路的调节,支持进一步转化研究。
局限性
- 研究为小鼠临床前模型,样本量每组8只,结果不能直接外推至临床患者。
- 仅评估机械性痛觉过敏和有限时间窗(术后第1至4天),未报告其他疼痛行为或长期结局。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND OBJECTIVES: AMP-activated protein kinase (AMPK) activator drugs decrease hypersensitivity in mice with pain. This study examines if postsurgery treatment with the prototype AMPK activator metformin and a new mechanism-specific AMPK activator, O304, after plantar hindpaw incision in mice, would reduce mechanical hypersensitivity and produce changes in the AMPK pathway in the dorsal root ganglion (DRG). METHODS: To create postoperative pain, an incision was made in the left plantar hindpaw. Animals were randomized into four oral gavage drug treatment groups (n=8/group): (1) vehicle, (2) metformin 200 mg/kg, (3) O304 200 mg/kg and (4) O304 200 mg/kg plus metformin 200 mg/kg. Drug gavages were performed 4 hours postsurgery and were repeated for 3 days. Mechanical hypersensitivity was measured with von Frey filaments. Changes in phosphorylated AMP-activated protein kinase alpha subunit, phosphorylated mechanistic target of rapamycin and phosphorylated eukaryotic initiation factor 2 alpha in DRG neurons were examined by immunohistochemistry. RESULTS: O304 or metformin increased von Frey thresholds (reduced mechanical hypersensitivity) in plantar incision mice versus vehicle-treated incision mice between days 1 and 4 (difference of mean area under the curve, O304: 2.24 g*day; 95% CI of the difference 0.28 to 4.21, p=0.011; metformin: 2.56 g*day; 95% CI of the difference 1.71 to 3.41, p<0.001). The drug combination further elevated von Frey thresholds. In the vehicle-treated group, the AMP-activated protein kinase alpha subunit was downregulated and mechanistic target of rapamycin and eukaryotic initiation factor 2 alpha were upregulated in DRG neurons; these deficits were reversed by the AMPK activator treatments. CONCLUSIONS: Early treatment with the mechanism-specific AMPK activator O304 or the prototype AMPK activator metformin reduces mechanical hypersensitivity in a postoperative pain model in mice. These drugs also normalize the AMPK pathway in the DRG.
引用
- Das V, Kroin JS, Moric M, et al. Antihyperalgesia effect of AMP-activated protein kinase (AMPK) activators in a mouse model of postoperative pain. Reg Anesth Pain Med. 2019. PMID: 31229963. doi:10.1136/rapm-2019-100651
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。